[Change in the phospholipid status in experimental silicosis in rats and in exposure to polymeric preparations].
D000818:Animals; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D005260:Female; D008168:Lung / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism*; D010879:Piperazines / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011144:Polyvinylpyridine N-Oxide / Q000627:therapeutic use*; D011145:Polyvinyls / Q000627:therapeutic use*; D051381:Rats; D012829:Silicosis / Q000188:drug therapy / Q000378:metabolism*; D013997:Time Factors
D003497:Cyclic N-Oxides; D010743:Phospholipids; D010879:Piperazines; D011145:Polyvinyls; D011092:Polyethylene Glycols; D011144:Polyvinylpyridine N-Oxide
Izmenenie sostoianiia fosfolipidov pri éksperimental'nom silikoze u krys i pri vozdeĭstvii polimernykh preparatov.